HEPA - AlphaYou

Smart money at a glance

Filings to Nov 5, 2026

Net buying: insiders sold $0 and bought $10K on the open market in 90 days (SEC Form 4). Congress: no trades disclosed in 180 days.

Company insidersSEC Form 4, last 90 days: +$10K netNet buying
CongressSTOCK Act, last 180 days: NoneNo trades disclosed
Big fundsSEC 13F, latest quarter: NoneNo large changes

Analysts

What do analysts expect?

Analyst target and ratings are on paid plans

See the 12-month consensus target and the buy/hold/sell rating split.

Unlock the full results

Questions about HEPA filings

Are insiders buying or selling Hepion Pharmaceuticals Inc (HEPA) stock?

Net buying: insiders sold $0 and bought $10K of HEPA stock on the open market in the 90 days to Nov 5, 2026, according to SEC Form 4 filings. The largest was Fisher, Danina (Director), who bought $10K. The latest filing was on Oct 2, 2026.

Which members of Congress have traded HEPA recently?

None. No member of Congress disclosed a HEPA trade with a trade date in the last 180 days, according to House and Senate STOCK Act filings.

How current is this HEPA smart-money data?

This summary uses filings available on Nov 5, 2026. Insiders must report trades to the SEC within 2 business days, members of Congress have up to 45 days to disclose a trade, and funds file 13F holdings up to 45 days after each quarter ends, so the latest moves may not be public yet.

Smart money on HEPA

Lean long1 source:
- Insiders

Top traders
No tracked positions at the last update
Insiders
Lean long3 buys · $610K
Form 4 filings, open market.
Politicians
No recent politician filings found
Funds
No recent fund filings found
Fin-fluencers
No recent posts found

Each bar is 100% of that source’s money. The notch marks an even split.

Lean is the direction of the latest moves. Descriptive, not advice.

Questions about HEPA filings

Are insiders buying or selling Hepion Pharmaceuticals Inc (HEPA) stock?

Which members of Congress have traded HEPA recently?

None. No member of Congress disclosed a HEPA trade with a trade date in the last 180 days, according to House and Senate STOCK Act filings.

How current is this HEPA smart-money data?

Insiders

What insiders are doing

6 trades · 6 mo

Bought$835K

Buys (3)

FD
Fisher Danina
Dir · Oct 2
$10K
bought
LV
Lopriore Vincent S
Executive Chairman · Held by Gravitas Capital LP · Cluster · Aug 13
$500K
bought
Signals like this: n=2409, 52% finished lower at D15, median -0.3% vs SPY +0.3%
SG
Stetz Gary S.
Interim CEO · Cluster · Aug 13
$100K
bought

2 more trades

Pro opens all of them for $16.50/month, paid yearly.

Unlock all 2 trades

Unlock everything for $29/month

Unlock for $29/month

Reported Aug 15, 2025

Results versus expectations

Documents

Quarterly report10-Q Annual report10-K Every filing

Last report

Aug 15, 2025

Period ending

Jun 30, 2025

Earnings per share

Unavailable

EPS comparison unavailable

Revenue

$0.00

SEC filing · No operating revenue

Next report

What the street expects next

Previous reports

Quarter / reported	Earnings per share	Beat or miss	Revenue / income	Revenue vs last year
Jun 30, 2025Reported Aug 15, 2025	Not on file	No estimate	$0.00SEC filing	No year-ago quarter
Mar 31, 2025Reported Apr 8, 2025	-$11.11est. -$1.97	-$9.14miss	Not on file	Not on file
Dec 31, 2024Reported Feb 26, 2025	-$11.12Reported	No estimate	Not on file	Not on file
Sep 30, 2024Reported Nov 14, 2024	-$0.72Reported	No estimate	Not on file	Not on file
Jun 30, 2024Reported Aug 13, 2024	-$0.68Reported	No estimate	Not on file	Not on file
Mar 31, 2024Reported May 21, 2024	Not on file	No estimate	$0.00SEC filing	No year-ago quarter
Sep 30, 2023Reported Nov 20, 2023	Not on file	No estimate	$0.00SEC filing	No year-ago quarter
Jun 30, 2023Reported Aug 14, 2023	Not on file	No estimate	$0.00SEC filing	No year-ago quarter

Earnings per share comes from Yahoo Finance where available, then Alpha Vantage or the company release. Revenue comes from company releases, SEC filings, Alpha Vantage or Yahoo Finance. A beat or miss needs an analyst estimate on the same basis as the reported figure, so quarters without one show none. Non-USD amounts carry their currency code.

52-wk high: $0.11
52-wk low: $0.03
Mkt cap: $2.6M
P/E: 0.1x
ROE: -2059.0%
Beta: 1.65
P/B: 15.8x
Profit margin: +0.0%
Op margin: +0.0%

Fundamentals

Is the business strong?

Fairly priced and running thin margins.

Net margin: 0.0%
P/E: 0.07
Market cap: $3M

Valuation

P/B15.85

Quality

Operating margin0.0%
ROE-2059.0%
ROA-100.4%

Growth

Beta1.65

Technicals

Price structure

Market data unavailable.

Smart money at a glance

Filings to Nov 5, 2026

Net buying: insiders sold $0 and bought $10K on the open market in 90 days (SEC Form 4). Congress: no trades disclosed in 180 days.

Company insidersSEC Form 4, last 90 days: +$10K netNet buying
CongressSTOCK Act, last 180 days: NoneNo trades disclosed
Big fundsSEC 13F, latest quarter: NoneNo large changes

Analysts

What do analysts expect?

Analyst target and ratings are on paid plans

See the 12-month consensus target and the buy/hold/sell rating split.

Unlock the full results

Questions about HEPA filings

Are insiders buying or selling Hepion Pharmaceuticals Inc (HEPA) stock?

Which members of Congress have traded HEPA recently?

None. No member of Congress disclosed a HEPA trade with a trade date in the last 180 days, according to House and Senate STOCK Act filings.

How current is this HEPA smart-money data?

Smart money on HEPA

Lean long1 source:
- Insiders

Top traders
No tracked positions at the last update
Insiders
Lean long3 buys · $610K
Form 4 filings, open market.
Politicians
No recent politician filings found
Funds
No recent fund filings found
Fin-fluencers
No recent posts found

Each bar is 100% of that source’s money. The notch marks an even split.

Lean is the direction of the latest moves. Descriptive, not advice.

Questions about HEPA filings

Are insiders buying or selling Hepion Pharmaceuticals Inc (HEPA) stock?

Which members of Congress have traded HEPA recently?

None. No member of Congress disclosed a HEPA trade with a trade date in the last 180 days, according to House and Senate STOCK Act filings.

How current is this HEPA smart-money data?

Insiders

What insiders are doing

6 trades · 6 mo

Bought$835K

Buys (3)

FD
Fisher Danina
Dir · Oct 2
$10K
bought
LV
Lopriore Vincent S
Executive Chairman · Held by Gravitas Capital LP · Cluster · Aug 13
$500K
bought
Signals like this: n=2409, 52% finished lower at D15, median -0.3% vs SPY +0.3%
SG
Stetz Gary S.
Interim CEO · Cluster · Aug 13
$100K
bought

2 more trades

Pro opens all of them for $16.50/month, paid yearly.

Unlock all 2 trades

Unlock everything for $29/month

Unlock for $29/month

Reported Aug 15, 2025

Results versus expectations

Documents

Quarterly report10-Q Annual report10-K Every filing

Last report

Aug 15, 2025

Period ending

Jun 30, 2025

Earnings per share

Unavailable

EPS comparison unavailable

Revenue

$0.00

SEC filing · No operating revenue

Next report

What the street expects next

Previous reports

Quarter / reported	Earnings per share	Beat or miss	Revenue / income	Revenue vs last year
Jun 30, 2025Reported Aug 15, 2025	Not on file	No estimate	$0.00SEC filing	No year-ago quarter
Mar 31, 2025Reported Apr 8, 2025	-$11.11est. -$1.97	-$9.14miss	Not on file	Not on file
Dec 31, 2024Reported Feb 26, 2025	-$11.12Reported	No estimate	Not on file	Not on file
Sep 30, 2024Reported Nov 14, 2024	-$0.72Reported	No estimate	Not on file	Not on file
Jun 30, 2024Reported Aug 13, 2024	-$0.68Reported	No estimate	Not on file	Not on file
Mar 31, 2024Reported May 21, 2024	Not on file	No estimate	$0.00SEC filing	No year-ago quarter
Sep 30, 2023Reported Nov 20, 2023	Not on file	No estimate	$0.00SEC filing	No year-ago quarter
Jun 30, 2023Reported Aug 14, 2023	Not on file	No estimate	$0.00SEC filing	No year-ago quarter

52-wk high: $0.11
52-wk low: $0.03
Mkt cap: $2.6M
P/E: 0.1x
ROE: -2059.0%
Beta: 1.65
P/B: 15.8x
Profit margin: +0.0%
Op margin: +0.0%

Fundamentals

Is the business strong?

Fairly priced and running thin margins.

Net margin: 0.0%
P/E: 0.07
Market cap: $3M

Valuation

P/B15.85

Quality

Operating margin0.0%
ROE-2059.0%
ROA-100.4%

Growth

Beta1.65

Technicals

Price structure

Market data unavailable.

Hepion Pharmaceuticals Inc

Smart money at a glance

What do analysts expect?

Questions about HEPA filings

Smart money on HEPA

Questions about HEPA filings

What insiders are doing

How top traders are positioned

Unlock everything for $29/month

Results versus expectations

What the street expects next

Previous reports

Is the business strong?

Price structure

Ask it in Claude or ChatGPT.

Hepion Pharmaceuticals Inc

Smart money at a glance

What do analysts expect?

Questions about HEPA filings

Smart money on HEPA

Questions about HEPA filings

What insiders are doing

How top traders are positioned

Unlock everything for $29/month

Results versus expectations

What the street expects next

Previous reports

Is the business strong?

Price structure

Ask it in Claude or ChatGPT.

Hepion Pharmaceuticals Inc

Overview

Questions about HEPA filings

Smart money

Unlock everything for $29/month

Earnings

Previous reports

Financials

Technicals

Ask it in Claude or ChatGPT.

Hepion Pharmaceuticals Inc

Overview

Questions about HEPA filings

Smart money

Unlock everything for $29/month

Earnings

Previous reports

Financials

Technicals

Ask it in Claude or ChatGPT.